Although the relationship between mutations in the MAPK/ERK pathway and potential malignant change or concomitant malignancy of RDD remains unclear, it provides a clue of the possible instability of the genome. This evidence concerns the gene MAPK1 and sinus histiocytosis with massive lymphadenopathy.